Aponia is a tablet from One Pharma Ltd., with the generic name Nabumetone. It is one of the treatment options a doctor may consider for joint pain and stiffness linked to these conditions.
There are 28 brands of Nabumetone listed in Bangladesh. 7 of them have a lower unit price than Aponia. The lowest listed price is Relanab 500 mg Tablet at ৳ 15 per unit.
What is Aponia 1000 mg Tablet?
Aponia comes as a tablet with 1000 mg of Nabumetone, from One Pharma Ltd. Nabumetone belongs to a group of medicines called non-steroidal anti-inflammatory drugs, often shortened to NSAIDs. By lowering these chemicals, the medicine helps relieve joint pain and stiffness. Whether it suits you is a decision for your doctor.
Uses of Aponia
It is one of the treatment options a doctor may consider for joint pain and stiffness linked to these conditions. The doctor also decides how long it should be taken. Aponia is used to relieve the signs and symptoms of osteoarthritis and rheumatoid arthritis in adults. Ask your doctor whether it is right for your condition.
How to use Aponia
Swallow or take it exactly as directed. Aponia is taken by mouth. Swallow the tablet with water. Take Aponia 1000 mg tablet exactly as the doctor tells you. Do not change the dose yourself and do not stop suddenly unless your doctor tells you. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Aponia
Some people notice dizziness, headache, tiredness, sweating, trouble sleeping, nervousness or drowsiness. The ones reported include diarrhoea, indigestion, abdominal pain, constipation, wind, nausea, vomiting, dry mouth, gastritis, dizziness, headache, tiredness, increased sweating, sleeplessness, nervousness, sleepiness, itching, rash, ringing in the ears and swelling. Seek medical help at once for severe stomach pain, black stools, vomiting blood, breathing problems or swelling of the face. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if side effects bother you or do not go away.
Safety and precautions
If you are pregnant, think you may be pregnant, or are breastfeeding, ask your doctor before taking it. Pregnancy category C means it should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. In pregnancy, it should be used only if the doctor decides the benefit justifies the risk; there are no adequate studies in pregnant women. Ask your doctor first if you have any ongoing health conditions or concerns.
Frequently asked questions
Why is Aponia prescribed?
It is one of the treatment options a doctor may consider for joint pain and stiffness linked to these conditions. The doctor also decides how long it should be taken.
How is Aponia used?
Swallow or take it exactly as directed. Aponia is taken by mouth.
What are the side effects of Aponia?
Some people notice dizziness, headache, tiredness, sweating, trouble sleeping, nervousness or drowsiness. The ones reported include diarrhoea, indigestion, abdominal pain, constipation, wind, nausea, vomiting, dry mouth, gastritis, dizziness, headache, tiredness, increased sweating, sleeplessness, nervousness, sleepiness, itching, rash, ringing in the ears and swelling.
Nabumetone is indicated for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis. Carefully consider the potential benefits and risks of Nabumetone and other treatment options before deciding to use Nabumetone. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals
Pharmacology
Nabumetone is a naphthylalkanone. Is is a non-selective prostaglandin G/H synthase (a.k.a. cyclooxygenase or COX) inhibitor that acts on both prostaglandin G/H synthase 1 and 2 (COX-1 and -2). Prostaglandin G/H synthase catalyzes the conversion of arachidonic acid to prostaglandin G2 and prostaglandin G2 to prostaglandin H2. Prostaglandin H2 is the precursor to a number of prostaglandins involved in fever, pain, swelling, inflammation, and platelet aggregation. The parent compound is a prodrug that undergoes hepatic biotransformation to the active compound, 6-methoxy-2-naphthylacetic acid (6MNA). The analgesic, antipyretic and anti-inflammatory effects of NSAIDs occur as a result of decreased prostaglandin synthesis.
The parent compound is a prodrug, which undergoes hepatic biotransformation to the active component, 6-methoxy-2-naphthylacetic acid (6MNA), that is a potent inhibitor of prostaglandin synthesis, most likely through binding to the COX-2 and COX-1 receptors.
Dosage & Administration
Osteoarthritis and Rheumatoid Arthritis: The recommended starting dose is 1,000 mg taken as a single dose with or without food. Some patients may obtain more symptomatic relief from 1,500 mg to 2,000 mg per day. Nabumetone can be given in either a single or twice-daily dose. Dosages greater than 2,000 mg per day have not been studied. The lowest effective dose should be used for chronic treatment. Patients weighing under 50 kg may be less likely to require dosages beyond 1,000 mg; therefore, after observing the response to initial therapy, the dose should be adjusted to meet individual patients’ requirements.
Interaction
Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors.
Contraindications
Nabumetone is contraindicated in patients with known hypersensitivity to nabumetone or its excipients. Nabumetone should not be given to patients who have experienced asthma, urticaria, or allergictype reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients. Nabumetone is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery
Pregnancy Category C. Reproductive studies conducted in rats and rabbits have not demonstrated evidence of developmental abnormalities. However, animal reproduction studies are not always predictive of human response. There are no adequate, well-controlled studies in pregnant women. Nabumetone should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.
Nursing Mothers: It is not known whether this drug is excreted in human milk, however 6MNA is excreted in the milk of lactating rats. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Nabumetone, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Labor and Delivery: In rat studies with NSAIDs, as with other drugs known to inhibit prostaglandin synthesis, an increased incidence of dystocia, delayed parturition, and decreased pup survival occurred. The effects of Nabumetone on labor and delivery in pregnant women are unknown.
Precautions & Warnings
Nabumetone cannot be expected to substitute for corticosteroids or to treat corticosteroid insufficiency. Abrupt discontinuation of corticosteroids may lead to disease exacerbation. Patients on prolonged corticosteroid therapy should have their therapy tapered slowly if a decision is made to discontinue corticosteroids. The pharmacological activity of Nabumetone in reducing fever and inflammation may diminish the utility of these diagnostic signs in detecting complications of presumed noninfectious, painful conditions
Overdose Effects
Symptoms following acute NSAIDs overdoses are usually limited to lethargy, drowsiness, nausea, vomiting, and epigastric pain, which are generally reversible with supportive care. Gastrointestinal bleeding can occur. Hypertension, acute renal failure, respiratory depression, and coma may occur, but are rare. Anaphylactoid reactions have been reported with therapeutic ingestion of NSAIDs, and may occur following an overdose.
Patients should be managed by symptomatic and supportive care following a NSAIDs overdose. There are no specific antidotes. Emesis and/or activated charcoal (60 to 100 grams in adults, 1 to 2 g/kg in children), and/or osmotic cathartic may be indicated in patients seen within 4 hours of ingestion with symptoms or following a large overdose (5 to 10 times the usual dose). Forced diuresis, alkalinization of urine, hemodialysis, or hemoperfusion may not be useful due to high protein binding.
There have been overdoses of up to 25 grams of Nabumetone reported with no long-term sequelae following standard emergency treatment (i.e., activated charcoal, gastric lavage, IV H2-blockers, etc.).
Storage Conditions
Store at 25°C; excursions permitted to 15-30°C in well-closed container; dispense in light-resistant container.
Alternative brands of Nabumetone
Other brands with the same generic name, cheapest first.